IRS2 is expressed at high levels in breast carcinoma cells of the basal-like/triple-negative breast cancer (TNBC) subtypes, and it regulates tumor cell migration, invasion, and glycolytic metabolism. The gene discussed is IRS2; the disease is breast carcinoma.